ID

29420

Description

Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor; ODM derived from: https://clinicaltrials.gov/show/NCT01048463

Link

https://clinicaltrials.gov/show/NCT01048463

Keywords

Versions (1)
  1. 3/22/18 3/22/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

March 22, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Gastric Cancer NCT01048463

English

Eligibility Gastric Cancer NCT01048463

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
the cases have undergone radical excision on gastric cancer or colorectal cancer.
Description

Radical excision Stomach Carcinoma | Radical excision Colorectal Carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0184918
UMLS CUI [1,2]
C0699791
UMLS CUI [2,1]
C0184918
UMLS CUI [2,2]
C0009402
without contraindication for chemotherapy.
Description

Medical contraindication Absent Chemotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0392920
eligible for postoperative adjuvant xelox chemotherapy.
Description

Eligibility XELOX Regimen Adjuvant Postoperative

Data type

boolean

Alias
UMLS CUI [1,1]
C1548635
UMLS CUI [1,2]
C1956962
UMLS CUI [1,3]
C1522673
UMLS CUI [1,4]
C0032790
capable of taking in food or drug orally.
Description

Able to swallow food | Able to swallow oral medication

Data type

boolean

Alias
UMLS CUI [1]
C0566359
UMLS CUI [2,1]
C2712086
UMLS CUI [2,2]
C0175795
without severe absorption dysfunction
Description

Absence Absorption Dysfunction Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0237442
UMLS CUI [1,3]
C3887504
UMLS CUI [1,4]
C0205082
able and willing to give written, informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
comorbidities: diseases of hematology or immunology system; hepatic or renal dysfunction; metabolic diseases.
Description

Comorbidity | Hematological Disease | Immune System Diseases | Liver Dysfunction | Renal dysfunction | Metabolic Diseases

Data type

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2]
C0018939
UMLS CUI [3]
C0021053
UMLS CUI [4]
C0086565
UMLS CUI [5]
C3279454
UMLS CUI [6]
C0025517
bmi>35kg/m2
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
life expectancy≤3mo
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
the chemotherapy treatment is palliative.
Description

Chemotherapy Palliative

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1285530
the patient has received radiotherapy or neoadjuvant chemotherapy prior to the operation.
Description

Therapeutic radiology procedure Preoperative | Chemotherapy Neoadjuvant Preoperative

Data type

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0445204
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0600558
UMLS CUI [2,3]
C0445204
Back to the top of the page

Similar models

Eligibility Gastric Cancer NCT01048463

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Radical excision Stomach Carcinoma | Radical excision Colorectal Carcinoma
Item
the cases have undergone radical excision on gastric cancer or colorectal cancer.
boolean
C0184918 (UMLS CUI [1,1])
C0699791 (UMLS CUI [1,2])
C0184918 (UMLS CUI [2,1])
C0009402 (UMLS CUI [2,2])
Medical contraindication Absent Chemotherapy
Item
without contraindication for chemotherapy.
boolean
C1301624 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
Eligibility XELOX Regimen Adjuvant Postoperative
Item
eligible for postoperative adjuvant xelox chemotherapy.
boolean
C1548635 (UMLS CUI [1,1])
C1956962 (UMLS CUI [1,2])
C1522673 (UMLS CUI [1,3])
C0032790 (UMLS CUI [1,4])
Able to swallow food | Able to swallow oral medication
Item
capable of taking in food or drug orally.
boolean
C0566359 (UMLS CUI [1])
C2712086 (UMLS CUI [2,1])
C0175795 (UMLS CUI [2,2])
Absence Absorption Dysfunction Severe
Item
without severe absorption dysfunction
boolean
C0332197 (UMLS CUI [1,1])
C0237442 (UMLS CUI [1,2])
C3887504 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,4])
Informed Consent
Item
able and willing to give written, informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Comorbidity | Hematological Disease | Immune System Diseases | Liver Dysfunction | Renal dysfunction | Metabolic Diseases
Item
comorbidities: diseases of hematology or immunology system; hepatic or renal dysfunction; metabolic diseases.
boolean
C0009488 (UMLS CUI [1])
C0018939 (UMLS CUI [2])
C0021053 (UMLS CUI [3])
C0086565 (UMLS CUI [4])
C3279454 (UMLS CUI [5])
C0025517 (UMLS CUI [6])
Body mass index
Item
bmi>35kg/m2
boolean
C1305855 (UMLS CUI [1])
Life Expectancy
Item
life expectancy≤3mo
boolean
C0023671 (UMLS CUI [1])
Chemotherapy Palliative
Item
the chemotherapy treatment is palliative.
boolean
C0392920 (UMLS CUI [1,1])
C1285530 (UMLS CUI [1,2])
Therapeutic radiology procedure Preoperative | Chemotherapy Neoadjuvant Preoperative
Item
the patient has received radiotherapy or neoadjuvant chemotherapy prior to the operation.
boolean
C1522449 (UMLS CUI [1,1])
C0445204 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0600558 (UMLS CUI [2,2])
C0445204 (UMLS CUI [2,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial